Trial Profile
Rapamycin in Combination With Low-dose Aracytin in Elderly Acute Myeloid Leukemia Patients. A Study From the Groupe Ouest Est d'étude Des Leucémies Aiguës Myéloïdes (GOELAMS)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 04 Mar 2024
Price :
$35
*
At a glance
- Drugs Cytarabine (Primary) ; Sirolimus (Primary)
- Indications Acute myeloid leukaemia
- Focus Therapeutic Use
- Acronyms GOELAMS; LAM-RAPA
- 19 Jul 2008 New trial record.